نتایج جستجو برای: meglumine antimoniate

تعداد نتایج: 930  

2013
Siavash M. Shanehsaz

Cutaneous leishmaniasis (CL) has been recognized as a major public health problem in several countries. It is highly endemic in the north and east Mediterranean regions in the Syrian Arab Republic with more than 75.9% of all CL cases recorded from these regions. Pentavalent antimonials have been considered as standard treatment for leishmaniasis. Use of pentavalent antimonials to treat leishman...

2016
Rosiana Estéfane da Silva Antonio Toledo Maria Camilo Senna Ana Rabello Gláucia Cota

Although intralesional meglumine antimoniate (MA) infiltration is considered an option for cutaneous leishmaniasis (CL) therapy and is widely used in the Old World, there have been few studies supporting this therapeutic approach in the Americas. This study aims to describe outcomes and adverse events associated with intralesional therapy for CL. This retrospective study reviewed the experience...

Journal: :International Journal of Peptide Research and Therapeutics 2023

An in vitro investigation was carried out to assess how the lipopeptide biosurfactant (LPB) produced by Acinetobacter junii B6 affects Leishmania tropica infection and associated cytokine gene expression macrophages infected with L. tropica. Glucantime® (meglumine antimoniate, MA) LPB were investigated for their leishmanicidal effect, alone combination (LPB + MA), using a colorimetric test macr...

2016
Iraj Mohammadpour Mohammad Hossein Motazedian Farhad Handjani Gholam Reza Hatam

Cutaneous leishmaniasis (CL) is a protozoan disease which is endemic in Iran. It is transmitted by the Phlebotomus sand fly. The eyelid is rarely involved possibly because the movement of the lids impedes the sand fly from biting the skin in this region. Here, we report 6 rare cases of eyelid CL. The patients were diagnosed by skin scraping, culture, and PCR from the lesions. Skin scraping exam...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000
H C Maltezou C Siafas M Mavrikou P Spyridis C Stavrinadis T Karpathios D A Kafetzis

Records were reviewed of 82 immunocompetent children (median age, 2. 5 years) from southern Greece who were diagnosed with visceral leishmaniasis from 1986 through 1998. Forty-nine (58%) patients originated from the city of Athens; of them, 46 (94%) lived by hills bordering the city. The median interval from the onset of symptoms to admission was 10 days. Fever and splenomegaly were observed in...

Amireh Heshmatkhah Iraj Sharifi Mehran Karvar Mohammad Hossein Daie Parizi Noushin Pouryazdanpanah Zahra Baziar

Background & Aims: It is more than half of a century that the drug of choice for treatment of cutaneous leishmaniosis (CL) has been pentavalent antimony compounds such as meglumine antimoniate (Glucantime). The aim of the present study was to evaluate the efficacy, relapse and treatment failure of intralesional Glucantime plus cryotherapy in the treatment of anthroponotic CL (ACL). Methods: The...

Journal: :Bulletin of the World Health Organization 1993
G Soleimanzadeh G H Edrissian A M Movahhed-Danesh A Nadim

During the last decade, kala-azar, which used to be a sporadic disease, became endemic in parts of East-Azerbaijan province in north-west Iran. Many of the 1051 cases observed between 1985 and 1990 were in the district of Meshkin-Shahr (800 cases). The diagnosis was based on symptoms and signs of the disease plus a positive serological test (indirect immunofluorescence assay or direct agglutina...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید